TMDX
$22.24
Transmedics Group
$.61
2.82%
TMDX
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.29)
Revenue:  $10.10 Mil
Tuesday
Aug 3
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TMDX reports earnings?
Beat
Meet
Miss

Where is TMDX's stock price going from here?
Up
Flat
Down
Stock chart of TMDX
Analysts
Summary of analysts' recommendations for TMDX
Score
Grade
Pivots
Resistance
$23.97
$23.43
$22.83

$22.29

Support
$21.69
$21.15
$20.55
Tweet
Growth
Description
TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation. TransMedics Inc. is headquartered in Andover, Massachusetts.